Human Immunoglobulin (IVIG) Showing Great Immune Modulating Function
Human Immunoglobulin for Intravenous Injection (IVIG) contains IgG antibodies of broad-spectrum anti-virus, bacteria or other pathogens. Idiotypic antibody and idiotype of immunoglobulin can form a complex immune network to contribute the dual therapeutic effects of immune replacement and immune regulation. After intravenous infusion, it will rapidly increase the lgG of the recipients, thus improve their anti-infection ability and immune regulatory function.
Immunoglobulin from the plasma of thousands of healthy blood donors is administered intravenously to patients to treat autoimmune diseases. IVIG has been used for decades in the treatment of inflammatory and autoimmune diseases. The human immunoglobulin can successfully restore the function of platelet count and promote the forming of blood clots in patients with autoimmune hematologic diseases. IVIG therapy has been shown effective to dozens of immune and inflammatory diseases, including Kawasaki disease, kidney transplantation, myasthenia gravis, chronic lymphocytic leukemia etc.
Many scientists have found that IVIG may have several therapeutic mechanisms of action. Although there are multiple binding sites in immunoglobulin to detect and remove harmful proteins with antibodies, some of the binding sites interact with cells and soluble proteins and influence the immune process and inflammation. IVIG also contains soluble proteins, including cytokines and chemokines. It may be one of the mechanisms by which it works.
TAG:  Hualan Biological, Human Immunoglobulin for Intravenous Injection